Epizyme Inc (NASDAQ:EPZM)

15.85
Delayed Data
As of Apr 20
 -0.20 / -1.25%
Today’s Change
9.30
Today|||52-Week Range
21.40
+26.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-55.0M-132.4M-110.2M-134.3M
 
 
 
 
 
Depreciation742.0K1.4M1.6M1.6M
 
 
 
 
 
Total Other Cash Flow6.9M49.9M10.5M11.7M
 
 
 
 
 
Funds From Operations-47.4M-81.1M-98.1M-121.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-12.0M-8.2M-1.6M-909.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-35.4M-72.9M-96.5M-120.4M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-229.9M-126.4M
 
 
 
Decrease In Investments0.000.0065.1M240.7M
 
 
 
Capital Expenditures-2.2M-183.0K-624.0K-984.0K
 
 
 
 
 
Other Investing - Uses0.00-40.0M0.000.00
 
 
Net Cash Flow Investing-2.2M-40.2M-165.4M113.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.00--------
Long Term Debt Reduction0.00-441.0K-561.0K-620.0K
 
 
 
 
Net Proceeds Stock Sale103.8M131.8M131.9M156.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing286.0K0.000.000.00
 
 
Other Uses - Financing--0.000.000.00--
Net Cash Flow - Financing104.1M131.3M131.4M155.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash66.5M18.2M-130.5M148.8M